Posted by krcoGenCure in Uncategorized on January 10, 2018
GenCure, a subsidiary of BioBridge Global, today opened the first phase of a new biomanufacturing center designed to address a critical roadblock slowing the advancement of cellular therapies and the field of regenerative medicine: A lack of access to large-scale stem cell manufacturing and support services required for cGMP (Current Good Manufacturing Process)-compliant production of […]
Posted by krcoGenCure in Uncategorized on September 15, 2017
GenCure is excited to announce the opening of our brand new biomanufacturing center. Our core resources have expanded to include in-house expertise in stem cell cGMP manufacturing, quality management, compliance, and testing, with the goal of developing new approaches for cell expansion and manufacturing.